MedTrace Logo

Sugammadex and Time to Extubation in Ophthalmic Surgery

NCT06632067 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 262

Last updated 2024-10-08

No results posted yet for this study

Summary

This study is to invastigate if patients treated with sugammadex compared to neostigmine/atropine would be extubate faster upon emergence of anesthesia.

Conditions

  • General Anesthesia Using Endotracheal Intubation
  • Ophthalmologic Surgical Procedure
  • Sugammadex
  • Neostigmine
  • Extubation Readiness

Interventions

DRUG

sugammadex

sugammadex used for neuromuscular reversal

DRUG

Neostigmine + Atropine

Neostigmine and Atropine used for neuromuscular reversal

Sponsors & Collaborators

  • China Medical University Hospital

    lead OTHER

Principal Investigators

  • Yi-Ying Chiang, MD · China Medical Univerity Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-01
Primary Completion
2023-08-31
Completion
2023-08-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06632067 on ClinicalTrials.gov